Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro.
| Image |  |
|---|---|
| Description | scientific article published on 16 April 2018 |
| Author/s |
author: Jakub Hofman |
| Publication date | April 16, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |